- Posts: 176
- Thank you received: 1
testing of Equivir against COVID-19
SINGAPORE, 2 March 2020 – Singapore Exchange-listed Singapore eDevelopment Limited (Stock Code 40V) (“SeD”) wishes to announce today that its wholly-owned U.S. biomedical subsidiary, Impact BioMedical, Inc., has, through its scientific research partner, GRDG Sciences, LLC. (“GRDG”), recently conducted an additional round of testing of Equivir, a patented medical treatment and preventative drug, against a broad range of viruses. The tests results revealed that Equivir performed well against a broad range of viruses and validates the results of previous laboratory testing conducted at multiple independent facilities. These tests demonstrate the ability of Equivir to control viruses responsible for deadly infectious diseases. ..............
|Southern Alliance Mining||1.000||-|
|Sri Trang Agro||1.410||0.040|
We have 1245 guests and no members online